Spinal muscular atrophy (SMA) is one of the major genetic disorders associated with infant
mortality. More than 90% cases of SMA result from deletions or mutations of Survival Motor …

RBM10 is a nuclear RNA-binding protein (RBP) that regulates the alternative splicing of
primary transcripts. Recently, research on RBM10 has become increasingly active owing to …

There are functional benefits to exercise in muscle, even when performed late in life, but the
contributions of epigenetic factors to late‐life exercise adaptation are poorly defined. Using …

Lung cancer (LC) is often diagnosed at an advanced stage and conventional treatments for
disease management have limitations associated with them. Novel therapeutic targets are …

Non-muscle-invasive bladder cancer (NMIBC) includes stage Ta and stage T1 tumors and
carcinoma in situ (CIS). Grading of Ta tumors subdivides these lesions into papillary …

Humans carry two nearly identical copies of Survival Motor Neuron gene: SMN1 and SMN2.
Mutations or deletions of SMN1, which codes for SMN, cause spinal muscular atrophy …

Abstract RNA-binding motif 10 (Rbm10) is an RNA-binding protein that regulates alternative
splicing, but its role in inflammation is not well defined. Here, we show that Rbm10 controls …

The tumor suppressor p53 acts as a transcription factor that regulates the expression of a
number of genes responsible for DNA repair, cell cycle arrest, metabolism, cell migration …

RBM10 is an RNA binding motif (RBM) protein expressed in most, if not all, human and
animal cells. Interest in RBM10 is rapidly increasing and its clinical importance is highlighted …

There is a discrepancy in the efficacy of epidermal growth factor receptor-tyrosine kinase
inhibitor (EGFR-TKI) treatment for advanced lung adenocarcinoma (LUAD) patients with …